The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group
Authors:
- Erik ThunnissenETErik Thunnissen
- Keith M. KerrKKKeith M. Kerr
- Felix J.F. HerthFHFelix J.F. Herth
- Sylvie LantuejoulSLSylvie Lantuejoul
- Mauro PapottiMPMauro Papotti
- Robert C. RintoulRRRobert C. Rintoul
- Giulio RossiGRGiulio Rossi
- Birgit G. SkovBSBirgit G. Skov
- Birgit WeynandBWBirgit Weynand
- Lukas BubendorfLBLukas Bubendorf
- Grünberg KatrienGKGrünberg Katrien
- Leif JohanssonLJLeif Johansson
- 1 April 2012
- journal article
- review article
- Published by Elsevier in Lung Cancer
- Vol. 76 (1) , 1-18
Abstract
No abstract availableKeywords
This publication has 219 references indexed in Scilit:
- A Platform for Rapid Detection of Multiple Oncogenic Mutations With Relevance to Targeted Therapy in Non–Small-Cell Lung CancerThe Journal of Molecular Diagnostics, 2011
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung CancerNew England Journal of Medicine, 2010
- HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testingVirchows Archiv, 2010
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary AdenocarcinomaNew England Journal of Medicine, 2009
- Epidermal growth factor receptor kinase domain mutations are rare in salivary gland carcinomasBritish Journal of Cancer, 2009
- Salivary gland-type lung carcinomas: an EGFR immunohistochemical, molecular genetic, and mutational analysis studyLaboratory Investigation, 2008
- Detection of drug-sensitizing EGFR exon 19 deletion mutations in salivary gland carcinomaBritish Journal of Cancer, 2008
- Comprehensive epidermal growth factor receptor gene analysis from cytological specimens of non-small-cell lung cancersBritish Journal of Cancer, 2007
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- Mutations of the BRAF gene in human cancerNature, 2002